Enlivex Therapeutics Ltd. Company Information

Enlivex Therapeutics Ltd.'s employee growth, exchange listings and data sources

Key Information

Name: Enlivex Therapeutics Ltd.
Ticker: ENLV
Exchange: TASE
Founded: NaN
Industry: Biotechnology
Sector: Pharmaceuticals & Biotech
Market Cap: US$18.002m
Listing Market Cap: US$66.723m
Shares Outstanding: 21.41m
Website: https://www.enlivex.com

Number of Employees

Location

Enlivex Therapeutics Ltd.
14 Einstein Street
Ness Ziona
7403618
Israel

Listings

Ticker	Exchange	Primary Security	Security Type	Country	Currency	Listed on
ENLV	NasdaqCM (Nasdaq Capital Market)	Yes	Ordinary Shares	US	USD	Mar 2019
1BT	DB (Deutsche Boerse AG)	Yes	Ordinary Shares	DE	EUR	Mar 2019
ENLV	TASE (The Tel-Aviv Stock Exchange)	Yes	Ordinary Shares	IL	ILS	Mar 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
Data	Last Updated (UTC time)
Company Analysis	2024/11/23 01:05
End of Day Share Price	2024/11/21 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.